JobeA. Pulmonary surfactant therapy. N Engl J Med1993; 328: 861–8.
2.
PhibbsCSPhibbsRHWakeleyASchlueterMASnidermanSTooleyWH. Cost effects of surfactant therapy for neonatal respiratory distress syndrome. J Pediatr1993; 123: 953–62.
3.
MauskopfJABackhouseMEJonesDWoldDEMammelMCMullenM. Synthetic surfactant for rescue treatment of respiratory distress syndrome in premature infants weighing from 700 to 1350 grams: Impact on hospital resource use and charges. J Pediatr1995; 126: 94–101.
4.
Package insert.Exosurf (colfosceril). Research Triangle Park, NC: Glaxo-Wellcome Inc., October 1994.
5.
Package insert.Survanta (beractant). Columbus, OH: Ross Products Division, Abbott Laboratories, October 1994.
6.
HorbarJDWrightLLSollRFWrightECFanaroffAAKoronesSB. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J Pediatr1993; 123: 757–66.
7.
SollRFHorbarJDLuceyJFMaurerMLevineDSternM. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Pediatrics1996; 97: 1–6.
